National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 9887 [2023-03175]
Download as PDF
<![CDATA[
ddrumheller on DSK120RN23PROD with NOTICES
Federal Register / Vol. 88, No. 31 / Wednesday, February 15, 2023 / Notices
73. Lauralee Miller, Murray, Utah, Court
of Federal Claims No: 22–1903V
74. Ciena Westrich, Phoenix, Arizona,
Court of Federal Claims No: 22–
1906V
75. Randy Ritchie, Savannah, Georgia,
Court of Federal Claims No: 22–
1907V
76. Lisa Snell on behalf of K. W.,
Phoenix, Arizona, Court of Federal
Claims No: 22–1909V
77. Suzanne Meeley, Drexel Hill,
Pennsylvania, Court of Federal
Claims No: 22–1911V
78. Gonzalo Lopez and Rosalia Lopez on
behalf of A. L., Phoenix, Arizona,
Court of Federal Claims No: 22–
1912V
79. Chelsea Hughes, Olney, Maryland,
Court of Federal Claims No: 22–
1917V
80. Tiffany Taylor on behalf of C. T.,
Stanford, Kentucky, Court of
Federal Claims No: 22–1918V
81. Aidan Walsh, Boston,
Massachusetts, Court of Federal
Claims No: 22–1919V
82. Aubrielle Smythe, Huntsville,
Alabama, Court of Federal Claims
No: 22–1920V
83. Sakinah Wood, Atlanta, Georgia,
Court of Federal Claims No: 22–
1924V
84. Alexander Kurk, St. Petersburg,
Florida, Court of Federal Claims No:
22–1930V
85. Joseph Pilcher, Los Angeles,
California, Court of Federal Claims
No: 22–1931V
86. John D. Sherwood, Lexington, Ohio,
Court of Federal Claims No: 22–
1934V
87. Lorraine Martin, Port Orange,
Florida, Court of Federal Claims No:
22–1936V
88. Lorraine Martin, Port Orange,
Florida, Court of Federal Claims No:
22–1937V
89. Anwesa Paul, Westfield, New Jersey,
Court of Federal Claims No: 22–
1938V
90. Danielle Spiller, Manalapan, New
Jersey, Court of Federal Claims No:
22–1939V
91. Elizabeth Cimino, Phoenix, Arizona,
Court of Federal Claims No: 22–
1940V
92. Prisca Thomas, Beverly Hills,
California, Court of Federal Claims
No: 22–1941V
[FR Doc. 2023–03184 Filed 2–14–23; 8:45 am]
VerDate Sep<11>2014
21:16 Feb 14, 2023
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Renewal of Centers of Biomedical
Research Excellence (COBRE) (Phase 2).
Date: March 2–3, 2023.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute of General Medical
Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892 (Virtual Meeting).
Contact Person: Nina Sidorova, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, MSC 6200, Room 3AN18–01,
Bethesda, Maryland 20892, 301–594–3663,
sidorova@nigms.nih.gov.
Information is also available on the
Institute’s/Center’s home page:
www.nigms.nih.gov/, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859,
Biomedical Research and Research Training,
National Institutes of Health, HHS)
Dated: February 9, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–03174 Filed 2–14–23; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4165–15–P
Jkt 259001
9887
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; George M. O’Brien
Kidney Consortium Review.
Date: March 29–31, 2023.
Time: 10:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Institutes of Health,
National Institute of Diabetes and Digestive
and Kidney Diseases, Democracy II, 6707
Democracy Blvd., Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Ann A. Jerkins, Ph.D.,
Scientific Review Officer, NIDDK/Scientific
Review Branch, National Institutes of Health,
6707 Democracy Blvd., Room 7013,
Bethesda, MD 20892, 301–594–2242,
jerkinsa@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: February 9, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–03175 Filed 2–14–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
E:\FR\FM\15FEN1.SGM
15FEN1
]]>Agencies
[Federal Register Volume 88, Number 31 (Wednesday, February 15, 2023)]
[Notices]
[Page 9887]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-03175]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; George M. O'Brien Kidney
Consortium Review.
Date: March 29-31, 2023.
Time: 10:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate cooperative agreement
applications.
Place: National Institutes of Health, National Institute of
Diabetes and Digestive and Kidney Diseases, Democracy II, 6707
Democracy Blvd., Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ann A. Jerkins, Ph.D., Scientific Review
Officer, NIDDK/Scientific Review Branch, National Institutes of
Health, 6707 Democracy Blvd., Room 7013, Bethesda, MD 20892, 301-
594-2242, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: February 9, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-03175 Filed 2-14-23; 8:45 am]
BILLING CODE 4140-01-P
